NEW YORK (GenomeWeb News) – Affymetrix has appointed Timothy Barabe to the chief financial officer post. He will run the firm's treasury and financial functions, investor relations, and its information technology departments. Barabe previously was senior VP and CFO at Human Genome Sciences, and he was CFO at Regent Medical. He also has worked in various roles at Novartis, including senior executive positions at CIBA Vision.
Barabe replaces John Batty, who was with Affymetrix for three years.
Claire Fraser-Liggett, director of the Institute for Genome Sciences at the University of Maryland School of Medicine, on Thursday was named to the Maryland Women's Hall of Fame at an event in Annapolis.
The award honors women who made unique and lasting contributions to the life of the state.
Fraser-Liggett launched the institute at UMB in 2007, and before that she spent nearly a decade as president and director of The Institute for Genomic Research.
Osmetech said that CFO David Sandilands is stepping down from his position. He is being replaced by Steven Kemper, who has served as SVP of finance for Osmetech technology, a subsidiary of the firm. Kemper also currently serves as president of Pacific Financial Consulting, a financial consulting firm.
Agilent Technologies has appointed Rick Burdsall, who currently is the firm's VP and chief information officer, to the newly created position of chief infrastructure officer. In the role, Burdsall will be responsible for IT, global sourcing, workplace services, and infrastructure integration related to the company's pending acquisition of Varian. He formerly was Agilent's VP of Information Technology Solution Services, and he also was a marketing manager in the Semiconductor Products Group at Hewlett-Packard.
NextBio has named Russ Altman of Stanford Medical School to serve on its scientific advisory board. Altman is a professor of bioengineering, genetics, and medicine and he is chair of Stanford's department of bioengineering.
Fredrik Dahl has been appointed chief technology officer at Olink Genomics, the firm said this week. Dahl will lead the company's R&D efforts, with a focus on developing its Selector technology and related products. Before joining Uppsala, Sweden-based Olink, Dahl held senior R&D positions at Complete Genomics and at Ion Torrent Systems.
Caris Life Sciences has appointed Dan Sawyers to be senior VP and chief accounting officer, and Greg Kelly to be senior VP of operations.
Sawyers formerly was CAO at SourceCorp, and he served as senior VP at McKesson Corporation's shared service center. He also has been chief auditor at Centex and he was a professional accounting fellow with the Office of Thrift Supervision in the US Treasury.
Kelly previously was VP of operations with Genco Supply Chain Solutions, and he was a director of operations at Dell.
Intus Healthcare has named five people to its scientific advisory board, which will oversee its Ovplex ovarian cancer diagnostic. The board includes: Amrit Takhar of Wansford and Kings Cliffe Practice, who also is a member of the Northamptonshire Local Medical Committee and the Strategic Management Group of the East Midlands Primary Care Research Network; Malcolm Padwich, who is clinical lead for gynecological cancer and colonoscopy for West Hertfordshire; Fergus Macpherson, who is national head of pathology with Spire Healthcare and who formerly was deputy hospital director at Spire Murrayfield Hospital; Louise Bayne, who is CEO of the ovarian cancer support network Ovacome and a member of the National Cancer Research Network; and Sean Kehoe, president of the British Gynecological Cancer Society and a medical advisor to Ovacome.
University of Cambridge Professor Shankar Balasubramanian has won the Innovator of the Year award from the UK's Biotechnology and Biological Sciences Research Council, an accolade that brings with it a prize of £10,000 ($15,000).
Balasubramanian won the award in recognition of his work on inventing and developing Solexa's sequencing technology. He was a co-founder of Solexa, which was purchased by Illumina in 2007. Balasubramanian also won the BBSRC's Commercial Innovator of the Year category.
Balasubramanian said that he accepted the award "on behalf of the many people who have made important contributions at many stages of the Solexa project," and he acknowledged Professor and Solexa Co-founder David Klenerman in particular.
Carl Fuller has joined Life Technologies as director of chemistry for genome systems, where he is primarily working on the SOLiD platform. Previously, he was a science fellow at GE Healthcare.
Promoted? Changing jobs? GenomeWeb wants to know. E-mail [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.